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SHORT COMMUNICATION
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Medullary carcinoma of the thyroid (MCT) is a cancer
which occurs both sporadically and as part of the inherited
tumour syndrome Multiple Endocrine Neoplasia Type IIA
(MEN IIA: see Schimke (1984) for review). In MEN IIA,
MCT is often associated with phaeochromocytoma. MEN
IIA is inherited as an autosomal dominant trait with
incomplete penetrance. Thus, in terms of the 'two hit' model
(Knudson, 1973), tumorigenesis in MEN IIA involves the
inheritance of a predisposition to cancer followed by the
unmasking of this predisposition by somatic events. MCT
resembles retinoblastoma and Wilms' tumour in that these
tumours also occur in sporadic and inherited forms. The
gene for the inherited form of retinoblastoma has been
localised to chromosome 13. Tumorigenesis in both the
inherited and sporadic forms of retinoblastoma is frequently
associated with the loss of alleles from chromosome 13
(Cavenee et al., 1983). This is consistent with the tumour
gene, which can arise somatically (in the sporadic form of
retinoblastoma) or be inherited (in the familial form), being
recessive. Events causing the general loss of alleles from the
chromosome 13 carrying the normal allele for the tumour
locus would lead to both tumorigenesis and a loss of
chromosome 13 heterozygosity in the tumour.
A similar mechanism of tumorigenesis occurs in Wilms'
tumour. The gene locus predisposing to Wilms' tumour has
been localised to the short arm of chromosome 11 (lip).
This gene also appears to be recessive since when loci on the
short arm of chromosome 11 were studied it was found that
in the tumour DNA, as compared to constitutive DNA from
the same patient, there was frequently a loss of alleles
leading to homozygosity along the short arm of chromosome
11 (Fearon et al., 1984; Koufos et al., 1984; Orkin et al.,
1984; Reeve et al., 1984). Loss of heterozygosity of lip loci
has also been correlated with bladder cancers (Fearon et al.,
1985) and with the occurrence of hepatoblastoma and
rhabdomyosarcoma in patients with the Beckwith-
Weidemann syndrome (Koufos et al., 1985). It is not known
whether the Wilms' tumour locus or some other lIp locus or
loci are involved in the development of these tumours.
Finally, the insertion of a hepatitis B virus leading to a
hepatocellular carcinoma was found to be associated with a
deletion (and hence loss of heterozygosity) around the viral
insertion site in lIp13-14 (Rogler et al., 1985). The insertion
site is distinct from the Wilms' tumour locus (Glaser et al.,
1986).
No linkage marker for MEN IIA has yet been found. A
deletion has been detected at chromosome 20pl2 in some
MEN IIA patients (Babu et al., 1984) but linkage analysis
has shown that the MEN IIA locus is unlikely to be in this
region (Goodfellow et al., 1985). If tumorigenesis in MEN
IIA occurs by a similar mechanism to that in retinoblastoma
and Wilms' tumour then the loss of alleles from a specific
chromosome in both sporadic and familial MCT and phaeo-
chromocytoma would imply that the locus for MEN IIA is
on that chromosome. We have investigated whether the
onset of MCT and phaeochromocytoma involves the loss of
alleles from chromosome lp. The short arm of chromosome
11 was studied for two reasons. Firstly, the calcitonin gene,
which is overexpressed in MCT, has been localised to
chromosome Ilp (Przepiorka et al., 1984), and in a cell
line derived from an MCT a chromosomal rearrangement
has been detected in the vicinity of the calcitonin gene
(Przepiorka et al., 1984). Secondly, the locus for Wilms'
tumour is in llpl3, and this locus, and perhaps other llp
loci are involved in the development of a variety of tumour
types.
In order to determine whether alleles were lost at specific
loci in tumour DNA, we made use of known DNA polymor-
phisms at these loci. These DNA polymorphisms can be
detected as restriction fragment length polymorphisms
(RFLPs) by Southern blotting. We examined constitutive
(lymphocyte) DNA and tumour DNA from five patients. We
looked for loci in the lymphocyte DNA samples which were
heterozygous for a particular polymorphism since in these
heterozygous cases both alleles of that locus can be seen on
a Southern blot. We then compared these heterozygous
lymphocyte loci with the corresponding tumour loci to assess
whether any alleles were lost in the tumour.
Patients 1, 2 and 3 had sporadic MCT. Patient 4 was from
an Irish MEN IIA family, had undergone thyroidectomy for
MCT but unlike other members of this kindred had not
developed phaeochromocytoma. Patient 5 was from a
Danish MEN IIA family and had been operated for both
MCT and bilateral phaeochromocytoma. Tumour DNA was
isolated from MCT samples of patients 1-4 and from a
phaeochromocytoma of patient 5. This DNA was obtained
during the course of tumour RNA preparation from frozen
tissue according to the method of Chirgwin et al. (1979) by
saving the DNA-containing fraction from the CsCI centri-
fugation step. This fraction was diluted to 10ml with 10mM
Tris-HCl pH7.5 containing 1 mM EDTA (TE), extracted
twice with TE-saturated phenol:chloroform (1:1), once with
chloroform, and the DNA precipitated by the addition of
1 ml 3M sodium acetate (pH5.5) and 2 volumes of absolute
ethanol. Precipitated DNA was redissolved in TE buffer.
Lymphocyte DNA was isolated from fresh or frozen
EDTA-blood (10ml). Briefly, 10ml Tris-HCl EDTA-blood
(fresh or thawed) was lysed by addition of 90ml 0.32M
sucrose, 10mM Tris-HCl pH7.5, 5mM MgCl2, 1% (v/v)
Triton X-100, and the nuclei removed by centrifugation at
l,OOOg for 10min. Nuclei were resuspended in 5ml 75mM
NaCl, 24mM EDTA pH8.0 and, following addition of 0.5ml
5% (w/v) SDS containing 2mgml-1 proteinase K, incubated
at 45°C for 6h. The mixture was then extracted twice with
TE-saturated phenol, once with chloroform:isoamyl alcohol
(24:1), and the DNA then precipitated from the aqueous
phase by the addition of 3M sodium acetate (pH5.5) to
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300 mM, and 2 volumes of ethanol. Precipitated DNA was
redissolved in TE buffer at 1 mgml-1 and stored at -20°C.
The five lymphocyte-tumour pairs were analysed at six loci
on the short arm of chromosome 11; calcitonin, parathyroid
hormone (PTH), Gy-globin, Ay-globin, c-Ha-ras 1 and
insulin. Linkage analysis (Kittur et al., 1985) has shown that
these genes are most likely ordered centromere-calcitonin-
PITH-globins-ras/insulin-telomere, spanning 45CM of DNA.
The insulin gene is in band lIpl5 (Harper et al., 1981). The
calcitonin gene was initially thought to be in the llpl3-14
region (Hoppener et al., 1984; Przepiorka et al., 1984) but
more recent evidence suggests it may be in 11 p15 (van
Heyningen et al., 1985). Therefore all the loci examined
probably reside in lp15.
We searched for loci which were heterozygous for the
following polymorphisms:
1. a polymorphic Taq I site in the calcitonin gene which
gives rise to Taq I alleles of 6.5 and 8.0 kilobases (kb)





2. a polymorphic Pst I site in the PTH gene which gives
rise to Pst I alleles of 2.2 and 2.7kb (Antonarakis et
al., 1983); to assist interpretation of this polymorphism
a non-polymorphic 2.2kb Pst I fragment was removed
by additional Hind III digestion (Vasicek et al., 1983;
Fearon et al., 1984);
3. polymorphic Hind III sites in the Gy- and Ay-globin
genes which give rise to Hind III alleles of 8.0 and
7.2kb from the Gy-globin gene and 3.5 and 2.7kb
from the Ay-globin gene (Jeffreys, 1979);
4. the presence of a variable number of tandem repeats 3'
to the c-Ha-ras 1 gene which gives rise to Bam HI
alleles of 6.9-8.5kb (Goldfarb et al., 1982) the most
common sizes being 6.9, 7.5, 8.0 and 8.3kb (Krontiris
et al., 1985);
5. the presence of a variable number of tandem repeats 5'
to the insulin gene which gives rise to Sac I alleles of







Figure 1 Southern analysis of lymphocyte and tumour DNA. Genomic DNA (8pg) was digested with the appropriate restriction
enzyme and electrophoresed through 0.6-0.8% agarose gels. Southern blotting (Southern, 1975) was performed using Genescreen
Plus membrane (NEN). Plasmid probes were radiolabelled to greater than 108cpmug-1 by nick-translation (Rigby et al., 1977)
using [a-32P]dCTP (NEN-800 Cimmol-1). Southern blots were hybridised and washed according to the manufacturers'
recommendations; final washes were in 0.2 x SSC (30mM NaCl, 3mM trisodium citrate) at 65°C. Blots were autoradiographed
using Kodak XAR-5 film and Cronex intensifying screens at -70°C.
In each panel track L is lymphocyte DNA and track T is tumour DNA. The sizes of alleles, calculated from marker tracks of A
restricted with Hind III (not shown), are indicated in kilobases. The numbers in brackets are the numbers used to refer to the
relevant alleles in Table I. Patient numbers are shown below each blot. A: Taq I-digested DNA probed with calcitonin probe; B:
Hind III-digested DNA probed with y-globin probe.
Table I Analysis of lp alleles in lymphocyte and tumour DNA
Patient I Patient 2 Patient 3 Patient 4 Patient 5
Sporadic Sporadic Sporadic MENIIA MENIIA
MCT MCT MCT MCT Phaeochromocytoma
Probe Normal Tumour Normal Tumour Normal Tumour Normal Tumour Normal Tumour
Calcitonin (Taq I) l,1 1,1 1,1 1,1 11,2 1,21 1,1 1,1 1,1 1,1
PTH (Pst I/HindIII) ND ND ND ND 1,1 1,1 1,1 1,1 1,2 1,2
Gy-globin (Hind III) 1,2 1,2 11,2 1,21 11,2 1,2 2,2 2,2 1,2 1,2
Ay-globin (Hind III) 1,2 1,2 2,2 2,2 2,2 2,2 2,2 2,2 1,2 1,2
c-Ha-ras 1 (Bam HI) 1,2 1,2 ND ND 2,2 2,2 3,3 3,3 2,3 2,3
Insulin (Sac I) ND ND ND ND ND ND 11,2 1,21 2,2 2,2
For the calcitonin, PTH, Gy-globin and Ay-globin genes polymorphic alleles are numbered with 1 being the smaller allele and 2
being the larger allele. For the c-Ha-ras 1 gene the alleles observed were 6.9 (1), 7.5 (2) and 8.0 (3)kb. For the insulin gene the
alleles observed were 6.0 (1) and 7.5 (2)kb. ND=Not determined. Informative loci are boxed.
The probes used were: phTB58, a cDNA clone derived from the calcitonin gene (Edbrooke et al., 1985); pPTHml22, a cDNA
clone derived from the parathyroid hormone gene (Hendy et al., 1981); JW151, a plasmid containing human y-globin sequences
(Wilson et al., 1978) which hybridises to both Gy- and Ay-globin genes under stringent conditions; pEJ (Shih & Weinberg, 1982)
containing a 6.6kb fragment spanning the c-Ha-ras I gene (Capon et al., 1983); phins 214, containing a 1.6kb fragment of the
insulin gene (Bell et al., 1984).
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Figure 1 shows two examples of Southern blots in which
lymphocyte DNA was found to be heterozygous. Patient 3
was heterozygous at the calcitonin gene. Both alleles were
retained in the MCT from this patient (Figure lA). Patient 5
was heterozygous at both the Gy- and Ay-globin genes. All
four alleles were retained in the phaeochromocytoma from
this patient (Figure 1B). Table I summarises the results for
the five lymphocyte-tumour pairs. The informative (hetero-
zygous) loci are boxed. At least one heterozygous locus was
found for each lymphocyte DNA sample. In all cases where
heterozygosity was seen in the lymphocyte DNA, this hetero-
zygosity was retained in the corresponding tumour DNA.
Thus no loss of lip alleles was observed in either sporadic
or inherited tumours. In comparable studies on Wilms'
tumour, 55% of patients examined showed loss of lp alleles
(Solomon, 1984). For example, Fearon et al. (1984), using
similar gene probes as ourselves, found loss of 1lp alleles in
four out of six Wilms' tumours. We conclude therefore that
the molecular basis of MEN IIA is unlikely to involve the
loss of material from the distal region of llp, and, assuming
that tumours in MEN IIA develop by similar mechanisms to
retinoblastoma and Wilms' tumours, then the locus for MEN
IIA is unlikely to be on the short arm of chromosome 11.
These results are in agreement with the studies of Kidd et al.
(1984) in which conventional linkage analysis was used to
exclude the MEN IIA locus from the PTH-globin-Ha-ras-
insulin region of lIp.
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